home / stock / oprx / oprx news


OPRX News and Press, OptimizeRx Corporation From 05/24/23

Stock Information

Company Name: OptimizeRx Corporation
Stock Symbol: OPRX
Market: NASDAQ
Website: optimizerx.com

Menu

OPRX OPRX Quote OPRX Short OPRX News OPRX Articles OPRX Message Board
Get OPRX Alerts

News, Short Squeeze, Breakout and More Instantly...

OPRX - Enveric, Zura top healthcare gainers; PTC Therapeutics, CohBar lead losers pack

2023-05-24 10:07:34 ET Gainers: Enveric Biosciences ( ENVB ) +100% . Zura Bio ( ZURA ) +37% . Kamada ( KMDA ) +19% . Organogenesis ( ORGO ) +16% . OptimizeRx ( OPRX ) +14% . Losers: PTC Therapeutics ( PTCT ) -24% ....

OPRX - OptimizeRx's CEO Provides 2023 Midyear Strategic Update

A leading suite of pharma tech solutions combined with deep brand penetration is driving revenue growth, resulting in improved profitability and KPIs through the remainder of 2023 and beyond With a comprehensive, digitally enabled enterprise point-of-care solution, the OptimizeRx platform n...

OPRX - OptimizeRx's Karina Castagna Named One of the 2023 PM360 ELITE 100

ROCHESTER, Mich., May 18, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy today announced that Karina Castagna, Senior Vice President of Access and...

OPRX - OptimizeRx Corporation (OPRX) Q1 2023 Earnings Call Transcript

2023-05-10 22:44:09 ET OptimizeRx Corporation (OPRX) Q1 2023 Earnings Conference Call May 10, 2023, 4:30 PM ET Company Participants Will Febbo - Chief Executive Officer Ed Stelmakh - Chief Financial and Operating Officer Steve Silvestro - Chief Commercial Officer...

OPRX - OptimizeRx Non-GAAP EPS of -$0.09 misses by $0.01, revenue of $13M beats by $0.64M

2023-05-10 16:07:01 ET OptimizeRx press release ( NASDAQ: OPRX ): Q1 Non-GAAP EPS of -$0.09 misses by $0.01 . Revenue of $13M (-5.3% Y/Y) beats by $0.64M . Gross profit in the first quarter of 2023 decreased 8% year-over-year to $7.4 million, from $8.1 million ...

OPRX - OptimizeRx Reports First Quarter 2023 Financial Results

Total revenue of $13.0 million GAAP net loss per share of $(0.37) Non-GAAP net loss per share of $(0.09) ROCHESTER, Mich., May 10, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutio...

OPRX - Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance

ROCHESTER, Mich., May 02, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced the results of a survey of more than 120 primary ca...

OPRX - OptimizeRx Sets First Quarter 2023 Conference Call for May 10, 2023at 4:30 p.m. ET

ROCHESTER, Mich., April 26, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy will hold a conference call on Wednesday, May 10, 2023 at ...

OPRX - OptimizeRx Releases 2023 Environmental, Social and Governance (ESG) Report

ROCHESTER, Mich., April 04, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy has published its 2023 Environmental, Social and Governance (ESG...

OPRX - OptimizeRx Has A Good Growth Path Ahead

2023-04-03 17:16:43 ET Summary OptimizeRx Corporation is an interesting company with an investment thesis based on its ability to capture a large TAM, with customers being some of the largest pharma companies out there. The company's financial position is robust and they have been...

Previous 10 Next 10